在NF1瘤抑制剂调节PD-L1和免疫逃避在黑色素瘤
Diana Berry1, Dan Moldoveanu2, Shivshankari Rajkumar1
1Rosalind and Morris Goodman Cancer Institute, McGill University, Montréal, QC H3A 1A3, Canada; Department of Biochemistry, McGill University, Montréal, QC H3G 1Y6, Canada.
Cell reports
|March 2, 2025
概括
在黑色素瘤中丧失NF1会增加PD-L1表达和T细胞逃逸,这表明抗PD-1疗法可能有利于NF1突变黑色素瘤患者. 这项研究阐明了NF1突变癌症中免疫逃避机制.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 皮肤黑色素瘤经常存在BRAF,NRAS和NF1的突变.
- 与BRAF和NRAS相比,NF1功能丧失突变在黑色素瘤中的作用不太清楚.
- NF1表现出RAS GTPase激活蛋白 (GAP) 依赖的和独立的瘤抑制功能.
研究的目的:
- 为了研究NF1损失在黑色素瘤中未被研究的作用.
- 探索使用抗PD-1免疫检查点抑制剂 (ICI) 治疗NF1-突变黑色素瘤患者高反应率背后的机制.
- 为了确定NF1损失是否影响PD-L1表达和T细胞相互作用.
主要方法:
- 研究了NF1和PD-L1.1之间的相互作用.
- 在具有NF1损失的黑色素瘤系中评估PD-L1细胞表面表达.
- 进行了黑色素瘤细胞和T细胞的共同培养实验,以评估T细胞杀死抵抗力.
- 在共同培养模型中使用抗PD-1/PD-L1免疫检查点抑制剂 (ICI).
主要成果:
- 黑色素瘤细胞中的NF1损失通过RAS-GAP独立途径增加PD-L1细胞表面表达.
- 减少NF1增强了黑色素瘤对T细胞中介杀伤的抵抗力.
- 在NF1缺乏的黑色素瘤中,对T细胞杀伤的抗性增加可以通过抗PD-1/PD-L1ICI逆转.
结论:
- 在黑色素瘤中,NF1损失通过PD-L1/PD-1轴促进免疫逃避.
- 这些发现支持对NF1突变黑色素瘤的抗PD-1疗法的研究.
- 这项研究表明,对于其他NF1突变癌症的潜在治疗策略.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
The Intrinsic Apoptotic Pathway
5.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.9K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K


